 |
|
| No | Structure | COMMON NAME | NAME | DATA No | INFORMANT | SYMBOL | FORMULA | MOL.WT(ave) | Download | BIOOGICAL ACTIVITY | PHYSICAL AND CHEMICAL PROPERTIES | SPECTRAL DATA | CHROMATOGRAM DATA | SOURCE | CHEMICAL SYNTHESIS | METABOLISM | GENETIC INFORMATION | NOTE | REFERENCES | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MELTING POINT | BOILING POINT | DENSITY | REFRACTIVE INDEX | OPTICAL ROTATION | SOLUBILITY | UV SPECTRA | IR SPECTRA | NMR SPECTRA | MASS SPECTRA | OTHER SPECTRA | ||||||||||||||||||
| 1 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C51:0 acid |
MMA0001 | Nagatoshi Fujiwara |
C49-diD(b-unit)+C22:0(a-unit) |
C71H138O3 | 1039.854 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 2 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C52:0 acid |
MMA0002 | Nagatoshi Fujiwara |
C50-diD(b-unit)+C22:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 3 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C53:0 acid |
MMA0003 | Nagatoshi Fujiwara |
C51-diD(b-unit+C22:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0003] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 4 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C54:0 acid |
MMA0004 | Nagatoshi Fujiwara |
C52-diD(b-unit)+C22:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0002] |
Mycobacterium vaccae(VA-1) (Ref. 0001/0004/0005) Mycobacterium parafortuitum(19686) (Ref. 0001/0004/0005) Mycobacterium diernhoferi(MD-1) (Ref. 0001/0004/0005) Mycobacterium phlei (Ref. 0005) Mycobacterium rhodesiae(RHO-1) (Ref. 0001/0004/0005) Mycobacterium aurum(Ref. 0004/0005) Mycobacterium kansasii (Ref. 0001) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 5 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C55:0 acid |
MMA0005 | Nagatoshi Fujiwara |
C53-diD(b-unit)+C22:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0003] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 6 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C56:0 acid |
MMA0006 | Nagatoshi Fujiwara |
C54-diD(b-unit)+C22:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0001](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0002] |
Mycobacterium vaccae(VA-1) (Ref. 0001/0004/0005) Mycobacterium parafortuitum(19686) (Ref. 0001/0004/0005) Mycobacterium diernhoferi(MD-1) (Ref. 0001/0004/0005) Mycobacterium phlei(Ref. 0001/0004/0005) Mycobacterium rhodesiae(RHO-1) (Ref. 0001/0004/0005) Mycobacterium duvalii(Ref. 0004) Mycobacterium gilvum(Ref. 0001) Mycobacterium aurum(Ref. 0004/0005) Mycobacterium kansasii(Ref. 0001/0005) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||
| 7 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C57:0 acid |
MMA0007 | Nagatoshi Fujiwara |
C55-diD(b-unit)+C22:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0003] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 8 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C58:0 acid |
MMA0008 | Nagatoshi Fujiwara |
C56-diD(b-unit)+C22:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0002] |
Mycobacterium parafortuitum(19686) (Ref. 0001/0004/0005) Mycobacterium diernhoferi(MD-1) (Ref. 0004) Mycobacterium phlei(Ref. 0001/0004/0005) Mycobacterium rhodesiae(RHO-1) (Ref. 0001/0004/0005) Mycobacterium vaccae(VA-1) (Ref. 0001/0004/0005) Mycobacterium agri(Ref. 0001) Mycobacterium gilvum(Ref. 0001/0004) Mycobacterium aurum(Ref. 0004/0005) Mycobacterium thermoresistibile(Ref. 0001) Mycobacterium pulveris(Ref. 0004) Mycobacterium kansasii(Ref. 0001/0005) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 9 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C59:0 acid |
MMA0009 | Nagatoshi Fujiwara |
C57-diD(b-unit)+C22:0(a-unit) |
C79H154O3 | 1152.066 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0003] |
Mycobacterium phlei(Ref. 0001/0004/0005) Mycobacterium agri(90012) (Ref. 0001) Mycobacterium aurum(Ref. 0005) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 10 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-dicyclopropanoyl-C60:0 acid |
MMA0010 | Nagatoshi Fujiwara |
C58-diD(b-unit)+C22:0(a-unit) |
C80H156O3 | 1166.093 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0002] |
Mycobacterium vaccae(VA-1) (Ref. 0005) Mycobacterium aurum(AU-1) (Ref. 0005) Mycobacterium thermoresistibile(Ref. 0001/0004/0005) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 11 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C50:0 acid |
MMA0011 | Nagatoshi Fujiwara |
C48-diD(b-unit)+C24:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0002](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0004] |
Mycobacterium vaccae(VA-1) (Ref. 0004/0005) Mycobacterium rhodesiae(Ref. 0001/0005) Mycobacterium marinum(Ref. 0005) Mycobacterium gordonae(Ref. 0005) Mycobacterium phlei(Ref. 0005) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||
| 12 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C51:0 acid |
MMA0012 | Nagatoshi Fujiwara |
C49-diD(b-unit)+C24:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 13 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C52:0 acid |
MMA0013 | Nagatoshi Fujiwara |
C50-diD(b-unit)+C24:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0003](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0004] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001), C71(Ref. 0004) |
||||||||||||||
| 14 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C53:0 acid |
MMA0014 | Nagatoshi Fujiwara |
C51-diD(b-unit)+C24:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 15 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C54:0 acid |
MMA0015 | Nagatoshi Fujiwara |
C52-diD(b-unit)+C24:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectra 0001/0004](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0004] |
Mycobacterium vaccae(VA-1) (Ref. 0001/0004/0005) Mycobacterium rhodesiae(RHO-1) (Ref. 0001/0004/0005) Mycobacterium phlei(Ref. 0001/0004/0005) Mycobacterium marinum(Ref. 0004/0005) Mycobacterium gordonae(Ref. 0004) Mycobacterium duvalii(Ref. 0004) Mycobacterium gilvum (Ref. 0001) Mycobacterium aurum(Ref. 0004/0005) Mycobacterium diernhoferi (Ref. 0001/0005) Mycobacterium kansasii(Ref. 0001/0005) Mycobacterium bovis(Ref. 0001) Mycobacterium tuberculosis(Ref. 0001) Mycobacterium ulcerans(Ref. 0004) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||
| 16 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C55:0 acid |
MMA0016 | Nagatoshi Fujiwara |
C53-diD(b-unit)+C24:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0004](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 17 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C56:0 acid |
MMA0017 | Nagatoshi Fujiwara |
C54-diD(b-unit)+C24:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0005](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0004] |
Mycobacterium vaccae(VA-1) (Ref. 0001/0004/0005) Mycobacterium rhodesiae(RHO-1) (Ref. 0001/0004/0005) Mycobacterium phlei(Ref. 0001/0004/0005) Mycobacterium marinum(Ref. 0005) Mycobacterium gordonae(Ref. 0004/0005) Mycobacterium agri(Ref. 0001/0004/0005) Mycobacterium gilvum(Ref. 0001/0004) Mycobacterium pulveris(Ref. 0004) Mycobacterium thermoresistible(Ref. 0001/0004/0005) Mycobacterium aurum (Ref. 0004/0005) Mycobacterium parafortuitum(Ref. 0001) Mycobacterium intracellulare(Ref. 0001) Mycobacterium kansasii(Ref. 0001/0005) Mycobacterium bovis(Ref. 0001) Mycobacterium tuberculosis(Ref. 0001) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||
| 18 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C57:0 acid |
MMA0018 | Nagatoshi Fujiwara |
C55-diD(b-unit)+C24:0(a-unit) |
C79H154O3 | 1152.066 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0005](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium agri(Ref. 0005) Mycobacterium thermoresistibile(Ref. 0005) Mycobacterium intracellulare(Ref. 0005) Mycobacterium kansasii(Lab.) (Ref. 0005) Mycobacterium marinum(Ref. 0005) Mycobacterium aurum(Ref. 0005) Mycobacterium phlei(Ref. 0001/0004/0005) Mycobacterium gordonae(Ref. 0005) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||
| 19 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C58:0 acid |
MMA0019 | Nagatoshi Fujiwara |
C56-diD(b-unit)+C24:0(a-unit) |
C80H156O3 | 1166.093 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0006](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0004] |
Mycobacterium agri(Ref. 0001/0004/0005) Mycobacterium aurum(Ref. 0005) Mycobacterium thermoresistibile(Ref. 0001/0004/0005) Mycobacterium phlei(Ref. 0004) Mycobacterium intracellulare(Ref. 0001/0004/0005) Mycobacterium kansasii(Lab.) (Ref. 0001/0004) Mycobacterium marinum(Ref. 0005) Mycobacterium gordonae(Ref. 0005) Mycobacterium gilvum(Ref. 0001) Mycobacterium avium(Ref. 0004/0005) Mycobacterium bovis(Ref. 0001) Mycobacterium tuberculosis(Ref. 0001) [Table 0001] [Table 0002] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||
| 20 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-dicyclopropanoyl-C60:0 acid |
MMA0020 | Nagatoshi Fujiwara |
C58-diD(b-unit)+C24:0(a-unit) |
C82H160O3 | 1194.146 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0007](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0001/0004] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 21 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C50:0 acid |
MMA0021 | Nagatoshi Fujiwara |
C48-diD(b-unit)+C26:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 22 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C51:0 acid |
MMA0022 | Nagatoshi Fujiwara |
C49-diD(b-unit)+C26:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 23 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C52:0 acid |
MMA0023 | Nagatoshi Fujiwara |
C50-diD(b-unit)+C26:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 24 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C53:0 acid |
MMA0024 | Nagatoshi Fujiwara |
C51-diD(b-unit)+C26:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 25 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C54:0 acid |
MMA0025 | Nagatoshi Fujiwara |
C52-diD(b-unit)+C26:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 26 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C55:0 acid |
MMA0026 | Nagatoshi Fujiwara |
C53-diD(b-unit)+C26:0(a-unit) |
C79H154O3 | 1152.066 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 27 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C56:0 acid |
MMA0027 | Nagatoshi Fujiwara |
C54-diD(b-unit)+C26:0(a-unit) |
C80H156O3 | 1166.093 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 28 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C57:0 acid |
MMA0028 | Nagatoshi Fujiwara |
C55-diD(b-unit)+C26:0(a-unit) |
C81H158O3 | 1180.119 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 29 |  |
Dicyclopropanoyl-a-mycolic acid |
2-Tetracosanoyl,3-hydroxy-dicyclopropanoyl-C58:0 acid |
MMA0029 | Nagatoshi Fujiwara |
C56-diD(b-unit)+C26:0(a-unit) |
C82H160O3 | 1194.146 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52 were existed in Mycobacterium microti(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) |
|||||||||||||||
| 30 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-monocyclopropanoyl-C49:1 acid |
MMA0030 | Nagatoshi Fujiwara |
C47:1(monoD)(b-unit)+C22:0(a-unit) |
C69H134O3 | 1011.800 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium diernhoferi(Ref. 0005) |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) a mycolic acid was existed in Mycobacterium fortuitum, Mycobacterium peregvium and Mycobacterium smegmatis.(Ref. 0006) |
||||||||||||||
| 31 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-monocyclopropanoyl-C51:1 acid |
MMA0031 | Nagatoshi Fujiwara |
C49:1(monoD)(b-unit)+C22:0(a-unit) |
C71HH138O3 | 1040.862 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 32 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-monocyclopropanoyl-C53:1 acid |
MMA0032 | Nagatoshi Fujiwara |
C51:1(monoD)(b-unit)+C22:0(a-unit) |
C73HH142O3 | 1068.915 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 33 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-monocyclopropanoyl-C55:1 acid |
MMA0033 | Nagatoshi Fujiwara |
C53:1(monoD)(b-unit)+C22:0(a-unit) |
C75HH146O3 | 1096.968 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 34 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-monocyclopropanoyl-C57:1 acid |
MMA0034 | Nagatoshi Fujiwara |
C55:1(monoD)(b-unit)+C22:0(a-unit) |
C77HH150O3 | 1125.021 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 35 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-monocyclopropanoyl-C59:1 acid |
MMA0035 | Nagatoshi Fujiwara |
C57:1(monoD)(b-unit)+C22:0(a-unit) |
C79HH154O3 | 1153.074 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 36 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-monocyclopropanoyl-C51:1 acid |
MMA0036 | Nagatoshi Fujiwara |
C49:1(monoD)(b-unit)+C24:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 37 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-monocyclopropanoyl-C53:1 acid |
MMA0037 | Nagatoshi Fujiwara |
C51:1(monoD)(b-unit)+C24:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 38 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-monocyclopropanoyl-C55:1 acid |
MMA0038 | Nagatoshi Fujiwara |
C53:1(monoD)(b-unit)+C24:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+) [Spectrum 0008](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 39 |  |
Monoenoic,monocyclopropanoyl-a-mycolic acid |
2-Docosanoyl,3-hydroxy-monocyclopropanoyl-C57:1 acid |
MMA0039 | Nagatoshi Fujiwara |
C55:1(monoD)(b-unit)+C24:0(a-unit) |
C79H154O3 | 1152.066 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 40 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C51:1 acid |
MMA0040 | Nagatoshi Fujiwara |
CH3-C49:1(monoD)(b-unit)+C22:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 41 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C53:1 acid |
MMA0041 | Nagatoshi Fujiwara |
CH3-C51:1(monoD)(b-unit)+C22:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 42 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C55:1 acid |
MMA0042 | Nagatoshi Fujiwara |
CH3-C53:1(monoD)(b-unit)+C22:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 43 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Ecosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C57:1 acid |
MMA0043 | Nagatoshi Fujiwara |
CH3-C55:1(monoD)(b-unit)+C22:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 44 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C59:1 acid |
MMA0044 | Nagatoshi Fujiwara |
CH3-C57:1(monoD)(b-unit)+C22:0(a-unit) |
C80H156O3 | 1166.093 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium phlei(Ref. 0004) |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 45 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C49:1 acid |
MMA0045 | Nagatoshi Fujiwara |
CH3-C47:1(monoD)(b-unit)+C24:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 46 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C51:1 acid |
MMA0046 | Nagatoshi Fujiwara |
CH3-C49:1(monoD)(b-unit)+C24:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 47 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C53:1 acid |
MMA0047 | Nagatoshi Fujiwara |
CH3-C51:1(monoD)(b-unit)+C24:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 48 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C55:1 acid |
MMA0048 | Nagatoshi Fujiwara |
CH3-C53:1(monoD)(b-unit)+C24:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
|||||||||||||||
| 49 |  |
Monomethyl,monocyclopropanoyl,monoenoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-monocyclopropanoyl-C57:1 acid |
MMA0049 | Nagatoshi Fujiwara |
CH3-C55:1(monoD)(b-unit)+C24:0(a-unit) |
C80H156O3 | 1166.093 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium phlei(Ref. 0004) |
DiD mycolic acids were existed in Mycobacterium tuberculosis.(Ref. 0011) a-unit, C24:0,C26:0; carbon chain length, L=17,18,19, M=10, N=15,17,19,21(Ref. 0016) a-unit, C26:0; carbon chain length C84(Ref. 0005) DiD mycolic acids were existed in Mycobacterium microti. a-unit, C26:0; carbon chain length, L+M+N=42,44,46,48,50,52(Ref. 0008) DiD mycolic acids (C80H156O3) were existed in Mycobacterium kansaii.(Ref. 0017) DiD mycolic acids were existed in Mycobacterium diernhoferi. a-unit, C22:0; carbon chain length C70(Ref. 0001),C71(Ref. 0004) It is reported that Mycobacterium phlei has mycolic acids with carbon chain length with C72,74,76,77,78,79,80 as diene(Ref. 0014), with C70,72,74,76,77,78,80 as diene(Ref. 0010) Increasing growth temperature resulted in an increase in longer chain species of mycolic acids with a concomitant decrease in shorter chain homologoues.(Ref. 0010/0014) |
||||||||||||||
| 50 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-octanoic acid |
MMA0050 | Nagatoshi Fujiwara |
C6:0(b-unit)+C14:0(a-unit) |
C20H40O3 | 328.530 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 51 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-decanoic acid |
MMA0051 | Nagatoshi Fujiwara |
C8:0(b-unit)+C14:0(a-unit) |
C22H44O3 | 356.583 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) [Spectrum 0009](Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 52 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-tetradecanoic acid |
MMA0052 | Nagatoshi Fujiwara |
C12:0(b-unit)+C14:0(a-unit) |
C26H52O3 | 412.689 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) [Spectrum 0010](Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 53 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-hexadecanoic acid |
MMA0053 | Nagatoshi Fujiwara |
C14:0(b-unit)+C14:0(a-unit) |
C28H56O3 | 440.742 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 54 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-decanoic acid |
MMA0054 | Nagatoshi Fujiwara |
C8:0(b-unit)+C16:0(a-unit) |
C24H48O3 | 384.636 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 55 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-dodecanoic acid |
MMA0055 | Nagatoshi Fujiwara |
C10:0(b-unit)+C16:0(a-unit) |
C26H52O3 | 412.689 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) [Spectrum 0010](Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 56 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-tetradecanoic acid |
MMA0056 | Nagatoshi Fujiwara |
C12:0(b-unit)+C16:0(a-unit) |
C28H56O3 | 440.742 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 57 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-hexadecanoic acid |
MMA0057 | Nagatoshi Fujiwara |
C14:0(b-unit)+C16:0(a-unit) |
C30H60O3 | 468.796 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) [Spectrum 0011](Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 58 |  |
(Corynomycolic acid) Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-octadecanoic acid |
MMA0058 | Nagatoshi Fujiwara |
C16:0(b-unit)+C16:0(a-unit) |
C32H64O3 | 496.849 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) [Spectrum 0012](Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 59 |  |
Monoenoic-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-tetradecanoic acid(C14:1) (or C16:1, C18:1) |
MMA0059 | Nagatoshi Fujiwara |
C12:1(b-unit)+C14:0(a-unit) |
C26H50O3 | 410.673 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 60 |  |
Monoenoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-dodecenoic acid(C12:1) (or C14:1, 16:1, 18:1) |
MMA0060 | Nagatoshi Fujiwara |
C10:1(b-unit)+C16:0(a-unit) |
C26H50O3 | 410.673 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 61 |  |
Dienoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C18:2 acid |
MMA0061 | Nagatoshi Fujiwara |
C16:2(b-unit)+C16:0(a-unit) |
C32H60O3 | 492.817 | |
Chloroform,n-Hexane |
A:[CH3-(CH2)m-CH-O-TMS] B:[-CH(-O-TMS)-CH(CO-O-CH3)-(CH2)n-CH3] (m=4 to 14, n=11 or 13) |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage) (Ref. 0027) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Corynebacterium ulcerans(Ref. 0027) |
The composition of mycolic acid in Corynebacterium diphtheriae. Carbon chain length C30,32 (70%), C24,26,28,34 (trace), odd-numbered carbon chain length (3%) (Ref. 0026) Mycobacterium leprosy isolated from human has C24-36 mycolic acids with 0-4 double bonds.(Ref. 0026) Isoniazide inhibits the synsesis of mycolic acid in sensitive strain.(Ref. 0019) |
|||||||||||||
| 62 |  |
Monoenoic-a-mycolic acid |
2-Hexadecanoyl,3-hydroxy-C44:1 acid (or C46:1, C48:1, C50:1) |
MMA0062 | Nagatoshi Fujiwara |
C42:1(b-unit)+C18:0(a-unit) |
C60H118O3 | 887.577 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 63 |  |
Monoenoic-a-mycolic acid |
2-Octadecanoyl,3-hydroxy-C42:1 acid (or C44:1, C46:1, C50:1, C52:1 acid) |
MMA0063 | Nagatoshi Fujiwara |
C40:1(b-unit)+C20:0(a-unit) |
C60H118O3 | 887.577 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 64 |  |
Monoenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C44:1 acid (or C46:1, C48:1, C50:1, C52:1) |
MMA0064 | Nagatoshi Fujiwara |
C42:1(b-unit)+C22:0(a-unit) |
C64H126O3 | 943.683 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 65 |  |
Dienoic-a-mycolic acid |
2-Hexadecanoyl,3-hydroxy-C46:2 acid (or C48:2, C50:2, C52:2, C54:2) |
MMA0065 | Nagatoshi Fujiwara |
C44:2(b-unit)+C18:0(a-unit) |
C62H120O3 | 913.614 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 66 |  |
Dienoic-a-mycolic acid |
2-Octadecanoyl,3-hydroxy-C44:2 acid (or C46:2, C48:2, C50:2, C52:2, C54:2) |
MMA0066 | Nagatoshi Fujiwara |
C42:2(b-unit)+C20:0(a-unit) |
C62H120O3 | 913.614 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 67 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C44:2 acid (or C46:2, C48:2, C50:2, C52:2, C54:2) |
MMA0067 | Nagatoshi Fujiwara |
C42:2(b-unit)+C22:0(a-unit) |
C64H124O3 | 941.668 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 68 |  |
Dienoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C46:1 acid (or C48:1, C50:1, C52:1, C54:1) |
MMA0068 | Nagatoshi Fujiwara |
C44:1(b-unit)+C20:1(a-unit) |
C64H124O3 | 941.668 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 69 |  |
Dienoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C44:1 acid (or C46:1, C48:1, C50:1, C52:1, C54:1) |
MMA0069 | Nagatoshi Fujiwara |
C42:1(b-unit)+C20:1(a-unit) |
C62H120O3 | 913.614 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 70 |  |
Trienoic-a-mycolic acid |
2-Hexadecanoyl,3-hydroxy-C48:3 acid (or C50:3, C52:3, C54:3) |
MMA0070 | Nagatoshi Fujiwara |
C46:3(b-unit)+C18:0(a-unit) |
C64H122O3 | 939.652 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0013](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 71 |  |
Trienoic-a-mycolic acid |
2-Octadecanoyl,3-hydroxy-C46:3 acid (or C48:3, C50:3, C52:3, C54:3, C56:3) |
MMA0071 | Nagatoshi Fujiwara |
C44:3(b-unit)+C20:0(a-unit) |
C64H122O3 | 939.652 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0013](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 72 |  |
Trienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C46:3 acid (or C48:3, C50:3, C52:3, C54:3) |
MMA0072 | Nagatoshi Fujiwara |
C44:3(b-unit)+C22:0(a-unit) |
C66H126O3 | 967.705 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 73 |  |
Trienoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C48:2 acid (or C50:2, C52:2, C54:2) |
MMA0073 | Nagatoshi Fujiwara |
C46:2(b-unit)+C20:1(a-unit) |
C66H126O3 | 967.705 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 74 |  |
Trienoic-a-mycolic acid |
2-Eicosenoyl,3-hydroxy-C46:2 acid (or C48:2, C50:2, C52:2, C54:2) |
MMA0074 | Nagatoshi Fujiwara |
C44:2(b-unit)+C22:1(a-unit) |
C66H126O3 | 967.705 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 75 |  |
Tetraenoic-a-mycolic acid |
2-Hexadecanoyl,3-hydroxy-C50:4 acid (or C52:4) |
MMA0075 | Nagatoshi Fujiwara |
C48:4(b-unit)+C18:0(a-unit) |
C66H124O3 | 965.689 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0014](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 76 |  |
Tetraenoic-a-mycolic acid |
2-Octadecanoyl,3-hydroxy-C48:4 acid (or C50:4, C52:4, C54:4, C56:4, C58:4) |
MMA0076 | Nagatoshi Fujiwara |
C46:4(b-unit)+C20:0(a-unit) |
C66H124O3 | 965.689 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 77 |  |
Tetraenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C48:4 acid (or C50:4, C52:4, C54:4, C56:4) |
MMA0077 | Nagatoshi Fujiwara |
C46:4(b-unit)+C22:0(a-unit) |
C68H128O3 | 993.742 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0015](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 78 |  |
Tetraenoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C48:3 acid (or C50:3, C52:3, C54:3, C56:3) |
MMA0078 | Nagatoshi Fujiwara |
C46:3(b-unit)+C20:1(a-unit) |
C66H124O3 | 965.689 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0014](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 79 |  |
Tetraenoic-a-mycolic acid |
2-Eicosenoyl,3-hydroxy-C48:3 acid (or C50:3, C52:3, C54:3, C56:3) |
MMA0079 | Nagatoshi Fujiwara |
C46:3(b-unit)+C22:1(a-unit) |
C68H128O3 | 993.742 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0015](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 80 |  |
Pentaenoic-a-mycolic acid |
2-Octadecanoyl,3-hydroxy-C52:5 acid (or C54:5, C56:5) |
MMA0080 | Nagatoshi Fujiwara |
C50:5(b-unit)+C20:0(a-unit) |
C70H130O3 | 1019.779 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 81 |  |
Pentaenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C50:5 acid (or C52:5, C54:5, C56:5) |
MMA0081 | Nagatoshi Fujiwara |
C48:5(b-unit)+C22:0(a-unit) |
C70H130O3 | 1019.779 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 82 |  |
Pentaenoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C52:4 acid (or C54:4, C56:4) |
MMA0082 | Nagatoshi Fujiwara |
C50:4(b-unit)+C20:1(a-unit) |
C70H130O3 | 1019.779 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 83 |  |
Pentaenoic-a-mycolic acid |
2-Eicosenoyl,3-hydroxy-C50:4 acid (or C52:4, C54:4, C56:4) |
MMA0083 | Nagatoshi Fujiwara |
C48:4(b-unit)+C22:1(a-unit) |
C70H130O3 | 1019.779 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 84 |  |
Hexaenoic-a-mycolic acid |
2-Octadecanoyl,3-hydroxy-C52:6 acid (or C54:6, C56:6, C58:6) |
MMA0084 | Nagatoshi Fujiwara |
C50:6(b-unit)+C20:0(a-unit) |
C70H128O3 | 1017.764 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 85 |  |
Hexaenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C54:6 acid (or C56:6, C58:6) |
MMA0085 | Nagatoshi Fujiwara |
C52:6(b-unit)+C22:0(a-unit) |
C74H136O3 | 1073.870 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 86 |  |
Hexaenoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C52:5 acid (or C54:5, C56:5) |
MMA0086 | Nagatoshi Fujiwara |
C50:5(b-unit)+C20:1(a-unit) |
C70H128O3 | 1017.764 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 87 |  |
Hexaenoic-a-mycolic acid |
2-Eicosenoyl,3-hydroxy-C54:5 acid (or C56:5) |
MMA0087 | Nagatoshi Fujiwara |
C52:5(b-unit)+C22:1(a-unit) |
C74H136O3 | 1073.870 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0016](Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 88 |  |
Heptaenoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C52:7 acid (or C54:7, C56:7, C58:7) |
MMA0088 | Nagatoshi Fujiwara |
C50:7(b-unit)+C22:0(a-unit) |
C72H130O3 | 1043.801 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 89 |  |
Heptaenoic-a-mycolic acid |
2-Octadecenoyl,3-hydroxy-C54:6 acid (or C56:6, C58:6) |
MMA0089 | Nagatoshi Fujiwara |
C52:6(b-unit)+C20:1(a-unit) |
C72H130O3 | 1043.801 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 90 |  |
Heptaenoic-a-mycolic acid |
2-Eicosenoyl,3-hydroxy-C52:6 acid (or C54:6, C56:6, C58:6) |
MMA0090 | Nagatoshi Fujiwara |
C50:6(b-unit)+C22:1(a-unit) |
C72H130O3 | 1043.801 | |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0024) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0005/0006] |
Gordona aurantiaca has two spotS of mycolic acid in TLC. Upper spot is carbon chain length, C60-78 and 2-7 double bond. Lower spot is C62-74, monoene, diene, triene, tetraene. The mycolic acid composition of Gordona is different from mycobacteria and nocardia.(Ref. 0024)The mycolic acid species of Gordona bronchialis is (a-unit C18:0) C58:0, C58:1 ,C60:1, C62:1, C58:2, C60:2, C62:2, C64:2, C60:3, C62:3, C64:3, C66:3, C62:4, C64:4, C66:4, C68:4, C64:5, C66:5, C68:5(Ref. 0022) |
|||||||||||||||
| 91 |  |
Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-C38:0 acid (or C40:0) |
MMA0091 | Nagatoshi Fujiwara |
C36:0(b-unit)+C14:0(a-unit) |
C50H100O3 | 749.327 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 92 |  |
Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C34:0 acid (or C36:0, C38:0, C40:0, C42:0, C44:0, C46:0) |
MMA0092 | Nagatoshi Fujiwara |
C32:0(b-unit)+C16:0(a-unit) |
C48H96O3 | 721.274 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 93 |  |
Saturated-a-mycolic acid |
2-Hexadecanoyl,3-hydroxy-C38:0 acid (or C40:0) |
MMA0093 | Nagatoshi Fujiwara |
C36:0(b-unit)+C16:0(a-unit) |
C52H104O3 | 777.380 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0017](Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 94 |  |
Monoenoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C34:1 acid (or C36:1, C38:1, C40:1, C42:1, C44:1, C46:1) |
MMA0094 | Nagatoshi Fujiwara |
C32:1(b-unit)+C16:0(a-unit) |
C48H94O3 | 719.258 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 95 |  |
Monoenoic-a-mycolic acid |
2-Tetradecenoyl,3-hydroxy-C36:0 acid(or C38:0, C40:0) |
MMA0095 | Nagatoshi Fujiwara |
C34:0(b-unit)+C16:1(a-unit) |
C50H98O3 | 747.311 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 96 |  |
Dienoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C34:2 acid (or C36:2, C38:2, C40:2, C42:2, C44:2, C46:2) |
MMA0096 | Nagatoshi Fujiwara |
C32:2(b-unit)+C16:0(a-unit) |
C48H92O3 | 717.242 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0018](Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 97 |  |
Dienoic-a-mycolic acid |
2-Tetradecenoyl,3-hydroxy-C36:1 acid (or C38:1, C40:1) |
MMA0097 | Nagatoshi Fujiwara |
C34:1(b-unit)+C16:1(a-unit) |
C50H96O3 | 745.295 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 98 |  |
Trienoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C36:3 acid (or C38:3, C40:3, C42:3, C44:3, C46:3, C48:3) |
MMA0098 | Nagatoshi Fujiwara |
C34:3(b-unit)+C16:0(a-unit) |
C50H94O3 | 743.280 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 99 |  |
Trienoic-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-C38:3 acid (or C40:3, C42:3) |
MMA0099 | Nagatoshi Fujiwara |
C36:3(b-unit)+C14:0(a-unit) |
C50H94O3 | 743.280 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 100 |  |
Trienoic-a-mycolic acid |
2-Tetradecenoyl,3-hydroxy-C42:2 acid |
MMA0100 | Nagatoshi Fujiwara |
C40:2(b-unit)+C16:1(a-unit) |
C56H106O3 | 827.439 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0019](Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 101 |  |
Tetraenoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C38:4 acid (or C40:4, C42:4, C44:4) |
MMA0101 | Nagatoshi Fujiwara |
C36:4(b-unit)+C16:0(a-unit) |
C52H96O3 | 769.317 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0020](Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 102 |  |
Tetraenoic-a-mycolic acid |
2-Tetradecenoyl,3-hydroxy-C38:3 acid (or C40:3, C42:3, C44:3) |
MMA0102 | Nagatoshi Fujiwara |
C36:3(b-unit)+C16:1(a-unit) |
C52H96O3 | 769.317 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0020](Ref. 0020) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0007/0008](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 103 |  |
Saturated-a-mycolic acid |
2-Octanoyl,3-hydroxy-tetracosanoic acid |
MMA0103 | Nagatoshi Fujiwara |
C22:0(b-unit)+C10:0(a-unit) |
C32H64O3 | 496.849 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0021](Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 104 |  |
Saturated-a-mycolic acid |
2-Nonanoyl,3-hydroxy-tetracosanoic acid |
MMA0104 | Nagatoshi Fujiwara |
C22:0(b-unit)+C11:0(a-unit) |
C33H66O3 | 510.875 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 105 |  |
Saturated-a-mycolic acid |
2-Decanoyl,3-hydroxy-docosanoic acid (or C23:0, C24:0, C25:0, C26:0) |
MMA0105 | Nagatoshi Fujiwara |
C20:0(b-unit)+C10:0(a-unit) |
C30H60O3 | 468.796 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 106 |  |
Saturated-a-mycolic acid |
2-Undecanoyl,3-hydroxy-tetracosanoic acid |
MMA0106 | Nagatoshi Fujiwara |
C22:0(b-unit)+C13:0(a-unit) |
C35H70O3 | 538.928 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 107 |  |
Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-docosanoic acid (or C23:0-C30:0, C32:0, C33:0) |
MMA0107 | Nagatoshi Fujiwara |
C20:0(b-unit)+C14:0(a-unit) |
C34H68O3 | 524.902 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0022](Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 108 |  |
Saturated-a-mycolic acid |
2-Tridecanoyl,3-hydroxy-tetracosanoic acid (or C26:0, C28:0) |
MMA0108 | Nagatoshi Fujiwara |
C22:0(b-unit)+C15:0(a-unit) |
C37H74O3 | 566.982 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 109 |  |
Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-tetracosanoic acid (or C26:0, C28:0-C32:0) |
MMA0109 | Nagatoshi Fujiwara |
C22:0(b-unit)+C16:0(a-unit) |
C38H76O3 | 581.008 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0023](Ref. 0023) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0009](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 110 |  |
Saturated-a-mycolic acid |
2-Decanoyl,3-hydroxy-octacosanoic acid |
MMA0110 | Nagatoshi Fujiwara |
C26:0(b-unit)+C12:0(a-unit) |
C38H76O3 | 581.008 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 111 |  |
Saturated-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-hexacosanoic acid (or C28:0, C30:0, C32:0) |
MMA0111 | Nagatoshi Fujiwara |
C24:0(b-unit)+C14:0(a-unit) |
C38H76O3 | 581.008 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 112 |  |
Saturated-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-tetracosanoic acid (or C26:0, C28:0, C30:0, C32:0, C34:0) |
MMA0112 | Nagatoshi Fujiwara |
C22:0(b-unit)+C16:0(a-unit) |
C38H76O3 | 581.008 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 113 |  |
Monoenoic-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-octacocenoic acid (or C30:1, C32:1, C34:1) |
MMA0113 | Nagatoshi Fujiwara |
C26:1(b-unit)+C14:0(a-unit) |
C40H78O3 | 607.046 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0024](Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 114 |  |
Monoenoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-hexacocenoic acid (or C28:1, C30:1, C32:1, C34:1, C36:1) |
MMA0114 | Nagatoshi Fujiwara |
C24:1(b-unit)+C16:0(a-unit) |
C40H78O3 | 607.046 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0024](Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 115 |  |
Dienoic-a-mycolic acid |
2-Dodecanoyl,3-hydroxy-C30:2 Acid (or C32:2, C34:2, C36:2) |
MMA0115 | Nagatoshi Fujiwara |
C28:2(b-unit)+C14:0(a-unit) |
C42H80O3 | 633.083 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 116 |  |
Dienoic-a-mycolic acid |
2-Tetradecanoyl,3-hydroxy-C28:2 acid (or C30:2, C32:2, C34:2, C36:2, C38:2, C40:2) |
MMA0116 | Nagatoshi Fujiwara |
C26:2(b-unit)+C16:0(a-unit) |
C42H80O3 | 633.083 | |
Dosage of isoniazide effects the species of myclic acid (increase of diene and shorter carbon chain length).(Ref. 0019) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0034/0038/0048/0057) Induction of macrophage chemotactic factor(Ref. 0035/0036) Antitumor activity(Ref. 0038) Induction of TNF-a(Ref. 0038) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0021) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0010/0011](Ref. 0018) |
The mycolic acid composition of Nocardia asteroides(Ref. 0022) The higher the growth temperature is, the more saturated species of mycolic acid is increased.(Ref. 0020) Nocardia 15 strains can be separated of four groups by mycolic acid species. the first is mainly saturated C34-50 (ex. N. erythropolis). The second is monoenoic, dienoic C34-50 (N. rubra, N. corallina, N. lutea). The third is 1-4 double bond C44-58 (N. polychromogenes). The last is 1-5 double bond C56-68 (N. polychromogenes). Nocardia rubra has C38-52, mainly C44:0, C46:1, C48:2 with C12:0 or C14:0 as 2-alkyl chain.(Ref. 0021) Nocardia erythropolis has C32-46, mainly saturated mycolic acids. |
||||||||||||||
| 117 |  |
Bacterionemamycolic acid |
2-Alkyl,3-hydroxy,long-chain fatty acid |
MMA0117 | Nagatoshi Fujiwara |
Cm(b-unit)+Cn(a-unit) m=10, 12-19, n=8, 10, 13-18 |
|
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0025](Ref. 0025) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0012] |
Bacterionema matruchotii(Ref. 0025) |
|||||||||||||||||
| 118 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C50:2 acid |
MMA0118 | Nagatoshi Fujiwara |
C48:2(b-unit)+C22:0(a-unit) |
C70H136O3 | 1025.827 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 119 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C51:2 acid |
MMA0119 | Nagatoshi Fujiwara |
C49:2(b-unit)+C22:0(a-unit) |
C71H138O3 | 1039.854 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 120 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C52:2 acid |
MMA0120 | Nagatoshi Fujiwara |
C50:2(b-unit)+C22:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 121 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C53:2 acid |
MMA0121 | Nagatoshi Fujiwara |
C51:2(b-unit)+C22:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 122 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C54:2 acid |
MMA0122 | Nagatoshi Fujiwara |
C52:2(b-unit)+C22:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0026](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001) Mycobacterium chitae(Ref. 0001) Mycobacterium fortuitum(Ref. 0001) Mycobacterium smegmatis(Ref. 0001) Mycobacterium diernhoferi(Ref. 0001/0004/0005) Mycobacterium parafortuitum(Ref. 0001/0004/0005) Mycobacterium rhodesiae(Ref. 0001/0004) Mycobacterium sp.strain 3707(Ref. 0001) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 123 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C55:2 acid |
MMA0123 | Nagatoshi Fujiwara |
C53:2(b-unit)+C22:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001) Mycobacterium chitae(Ref. 0001) Mycobacterium fortuitum(Ref. 0001) Mycobacterium smegmatis(Ref. 0001) Mycobacterium diernhoferi(Ref. 0004/0005) Mycobacterium parafortuitum(Ref. 0001/0004/0005) Mycobacterium rhodesiae(Ref. 0001/0004) Mycobacterium nonchromogenicum(Ref. 0001) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 124 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C57:2 acid |
MMA0124 | Nagatoshi Fujiwara |
C55:2(b-unit)+C22:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001) Mycobacterium chitae(Ref. 0001) Mycobacterium fortuitum(Ref. 0001) Mycobacterium smegmatis(Ref. 0001) Mycobacterium diernhoferi(Ref. 0004) Mycobacterium parafortuitum(Ref. 0001/0004/0005) Mycobacterium rhodesiae(Ref. 0001) Mycobacterium novum(Ref. 0001) Mycobacterium nonchromogenicum(Ref. 0001) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 125 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C56:2 acid |
MMA0125 | Nagatoshi Fujiwara |
C54:2(b-unit)+C22:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 126 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C58:2 acid |
MMA0126 | Nagatoshi Fujiwara |
C56:2(b-unit)+C22:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 127 |  |
Dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy-C59:2 acid |
MMA0127 | Nagatoshi Fujiwara |
C57:2(b-unit)+C22:0(a-unit) |
C79H154O3 | 1152.066 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium nonchromogenicum(Ref. 0001) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 128 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C46:2 acid |
MMA0128 | Nagatoshi Fujiwara |
C44:2(b-unit)+C24:0(a-unit) |
C68H132O3 | 997.774 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium sp.strain 3707(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 129 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C47:2 acid |
MMA0129 | Nagatoshi Fujiwara |
C45:2(b-unit)+C24:0(a-unit) |
C69H134O3 | 1011.800 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium sp.strain 3707(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 130 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C48:2 acid |
MMA0130 | Nagatoshi Fujiwara |
C46:2(b-unit)+C24:0(a-unit) |
C70H136O3 | 1025.827 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium sp.strain 3707(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 131 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C49:2 acid |
MMA0131 | Nagatoshi Fujiwara |
C47:2(b-unit)+C24:0(a-unit) |
C71H138O3 | 1039.854 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium sp.strain 3707(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 132 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C50:2 acid |
MMA0132 | Nagatoshi Fujiwara |
C48:2(b-unit)+C24:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0027](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 133 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C51:2 acid |
MMA0133 | Nagatoshi Fujiwara |
C49:2(b-unit)+C24:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 134 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C52:2 acid |
MMA0134 | Nagatoshi Fujiwara |
C50:2(b-unit)+C24:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0028](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001/0004/0005) Mycobacterium chitae(Ref. 0004/0005) Mycobacterium fortuitum(Ref. 0001/0004/0005) Mycobacterium smegmatis(Ref. 0001/0005) Mycobacterium diernhoferi(Ref. 0001) Mycobacterium rhodesiae(Ref. 0001/0004) Mycobacterium nonchromogenicum(Ref. 0005) Mycobacterium sp.strain 3707(Ref. 0001/0005) Mycobacterium szulgai(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 135 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C53:2 acid |
MMA0135 | Nagatoshi Fujiwara |
C51:2(b-unit)+C24:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0029](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001/0005) Mycobacterium chitae(Ref. 0001/0004/0005) Mycobacterium fortuitum(Ref. 0001/0005) Mycobacterium smegmatis(Ref. 0001/0004/0005) Mycobacterium rhodesiae(Ref. 0001/0004) Mycobacterium nonchromogenicum(Ref. 0001/0005) Mycobacterium terrae(Ref. 0005) Mycobacterium sp.strain 3707(Ref. 0005) Mycobacterium szulgai(Ref. 0005) Mycobacterium novum(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 136 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C54:2 acid |
MMA0136 | Nagatoshi Fujiwara |
C52:2(b-unit)+C24:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectra 0030/0031](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001/0004/0005) Mycobacterium chitae(Ref. 0001/0004/0005) Mycobacterium peregrinum PE-1(Ref. 0004) Mycobacterium fortuitum(Ref. 0001/0004/0005) Mycobacterium smegmatis(Ref. 0001/0005) Mycobacterium rhodesiae(Ref. 0001/0004) Mycobacterium terrae(Ref. 0005) Mycobacterium novum(Ref. 0005) Mycobacterium sp.strain 3707(Ref. 0005) Mycobacterium scrofulaceum(Ref. 0005) Mycobacterium szulgai(Ref. 0005) Mycobacterium diernhoferi(Ref. 0001) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 137 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C55:2 acid |
MMA0137 | Nagatoshi Fujiwara |
C53:2(b-unit)+C24:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectra 0031/0032](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001/0004/0005) Mycobacterium chitae(Ref. 0001/0004/0005) Mycobacterium porcinum(Ref. 0004) Mycobacterium fortuitum(Ref. 0001/0005) Mycobacterium smegmatis(Ref. 0001/0004/0005) Mycobacterium parafortuitum(Ref. 0001) Mycobacterium hodesiae(Ref. 0001) Mycobacterium nonchromogenicum(Ref. 0001/0004/0005) Mycobacterium terrae(Ref. 0005) Mycobacterium novum(Ref. 0001/0005) Mycobacterium scrofulaceum(Ref. 0005) Mycobacterium szulgai(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 138 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C56:2 acid |
MMA0138 | Nagatoshi Fujiwara |
C54:2(b-unit)+C24:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectra 0033/0034](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001/0004/0005) Mycobacterium chitae(Ref. 0001/0004/0005) Mycobacterium fortuitum(Ref. 0001/0004/0005) Mycobacterium smegmatis(Ref. 0001/0005) Mycobacterium parafortuitum(Ref. 0001/0005) Mycobacterium rhodesiae(Ref. 0001/0004) Mycobacterium nonchromogenicum(Ref. 0005) Mycobacterium terrae(Ref. 0005) Mycobacterium novum(Ref. 0005) Mycobacterium scrofulaceum(Ref. 0005) Mycobacterium szulgai(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 139 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C57:2 acid |
MMA0139 | Nagatoshi Fujiwara |
C55:2(b-unit)+C24:0(a-unit) |
C79H154O3 | 1152.066 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectra 0034/0035](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001) Mycobacterium chitae(Ref. 0001/0004/0005) Mycobacterium fortuitum(Ref. 0001/0005) Mycobacterium smegmatis(Ref. 0001/0005) Mycobacterium nonchromogenicum(Ref. 0001/0005) Mycobacterium terrae(Ref. 0004/0005) Mycobacterium novum(Ref. 0001/0004/0005) Mycobacterium triviale(Ref. 0004) Mycobacterium scrofulaceum(Ref. 0005) Mycobacterium szulgai(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 140 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C58:2 acid |
MMA0140 | Nagatoshi Fujiwara |
C56:2(b-unit)+C24:0(a-unit) |
C80H156O3 | 1166.093 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium chelonae(Ref. 0001) Mycobacterium chirae(Ref. 0005) Mycobacterium fortuitum(Ref. 0001/0004) Mycobacterium smegmatis(Ref. 0001/0004) Mycobacterium nonchromogenicum(Ref. 0001/0005) Mycobacterium terrae(Ref. 0005) Mycobacterium novum(Ref. 0005) Mycobacterium scrofulaceum(Ref. 0005) Mycobacterium szulgai(Ref. 0005) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 141 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C59:2 acid |
MMA0141 | Nagatoshi Fujiwara |
C57:2(b-unit)+C24:0(a-unit) |
C81H158O3 | 1180.119 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 142 |  |
Dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy-C60:2 acid |
MMA0142 | Nagatoshi Fujiwara |
C58:2(b-unit)+C24:0(a-unit) |
C82H160O3 | 1194.146 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0036](Ref. 0001/0005/0010) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 143 |  |
Dienoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C46:2 acid |
MMA0143 | Nagatoshi Fujiwara |
C44:2(b-unit)+C22:0(a-unit) |
C66H128O3 | 969.721 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
Mycobacterium fortuitum(Ref. 0001) |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
|||||||||||||
| 144 |  |
Dienoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C42:2 acid |
MMA0144 | Nagatoshi Fujiwara |
C40:2(b-unit)+C24:0(a-unit) |
C64H124O3 | 941.668 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 145 |  |
Dienoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C44:2 acid |
MMA0145 | Nagatoshi Fujiwara |
C42:2(b-unit)+C24:0(a-unit) |
C66H128O3 | 969.721 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 146 |  |
Dienoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C48:2 acid |
MMA0146 | Nagatoshi Fujiwara |
C46:2(b-unit)+C24:0(a-unit) |
C70H136O3 | 1025.827 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 147 |  |
Dienoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C46:2 acid |
MMA0147 | Nagatoshi Fujiwara |
C44:2(b-unit)+C24:0(a-unit) |
C68H132O3 | 997.774 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0037](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
In Mycobacterium smegmatis, l=15,17,19, m=11,13, n=16,18,20, x=21(Ref. 0007), C75-79,a-unit, C24:0(Ref. 0003)The composition effected by growth temperature.(Ref. 0010) In Mycobacterium phlei, C72, 74, 76-80 (or dicyclopropanring) (Ref. 0010/0014) In Mycobacterium bovis, C74-88, a-unit C22:0 or C24:0(Ref. 0015) |
||||||||||||||
| 148 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C51:2 acid |
MMA0148 | Nagatoshi Fujiwara |
CH3-C49:2(b-unit)+C22:0(a-unit) |
C72H140O3 | 1053.880 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 149 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C52:2 acid |
MMA0149 | Nagatoshi Fujiwara |
CH3-C50:2(b-unit)+C22:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 150 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C53:2 acid |
MMA0150 | Nagatoshi Fujiwara |
CH3-C51:2(b-unit)+C22:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 151 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C54:2 acid |
MMA0151 | Nagatoshi Fujiwara |
CH3-C52:2(b-unit)+C22:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 152 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C55:2 acid |
MMA0152 | Nagatoshi Fujiwara |
CH3-C53:2(b-unit)+C22:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 153 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C56:2 acid |
MMA0153 | Nagatoshi Fujiwara |
CH3-C54:2(b-unit)+C22:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 154 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Eicosanoyl,3-hydroxy,monomethyl-C57:2 acid |
MMA0154 | Nagatoshi Fujiwara |
CH3-C55:2(b-unit)+C22:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0001] |
|||||||||||||||
| 155 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C49:2 acid |
MMA0155 | Nagatoshi Fujiwara |
CH3-C47:2(b-unit)+C24:0(a-unit) |
C72H140O3 | 1053.880 | |
CCD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 156 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C50:2 acid |
MMA0156 | Nagatoshi Fujiwara |
CH3-C48:2(b-unit)+C24:0(a-unit) |
C73H142O3 | 1067.907 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 157 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C51:2 acid |
MMA0157 | Nagatoshi Fujiwara |
CH3-C49:2(b-unit)+C24:0(a-unit) |
C74H144O3 | 1081.933 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 158 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C52:2 acid |
MMA0158 | Nagatoshi Fujiwara |
CH3-C50:2(b-unit)+C24:0(a-unit) |
C75H146O3 | 1095.960 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 159 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C53:2 acid |
MMA0159 | Nagatoshi Fujiwara |
CH3-C51:2(b-unit)+C24:0(a-unit) |
C76H148O3 | 1109.987 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 160 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C54:2 acid |
MMA0160 | Nagatoshi Fujiwara |
CH3-C52:2(b-unit)+C24:0(a-unit) |
C77H150O3 | 1124.013 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0038](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 161 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C55:2 acid |
MMA0161 | Nagatoshi Fujiwara |
CH3-C53:2(b-unit)+C24:0(a-unit) |
C78H152O3 | 1138.040 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 162 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C56:2 acid |
MMA0162 | Nagatoshi Fujiwara |
CH3-C54:2(b-unit)+C24:0(a-unit) |
C78H154O3 | 1140.056 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 163 |  |
Monomethyl,dienoic-a-mycolic acid |
2-Docosanoyl,3-hydroxy,monomethyl-C58:2 acid |
MMA0163 | Nagatoshi Fujiwara |
CH3-C56:2(b-unit)+C24:0(a-unit) |
C81H158O3 | 1180.119 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
|||||||||||||||
| 164 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C38:1 acid |
MMA0164 | Nagatoshi Fujiwara |
C36:1(b-unit)+C24:0(a-unit) |
C60H118O3 | 887.577 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 165 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C34:1 acid |
MMA0165 | Nagatoshi Fujiwara |
C32:1(b-unit)+C24:0(a-unit) |
C56H110H3 | 786.496 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chitae(Ref. 0001) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 166 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C36:1 acid |
MMA0166 | Nagatoshi Fujiwara |
C34:1(b-unit)+C24:0(a-unit) |
C58H114O3 | 859.524 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 167 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C37:1 acid |
MMA0167 | Nagatoshi Fujiwara |
C35:1(b-unit)+C24:0(a-unit) |
C59H116O3 | 873.551 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 168 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C39:1 acid |
MMA0168 | Nagatoshi Fujiwara |
C37:1(b-unit)+C24:0(a-unit) |
C61H120O3 | 901.604 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 169 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C40:1 acid |
MMA0169 | Nagatoshi Fujiwara |
C38:1(b-unit)+C24:0(a-unit) |
C62H122O3 | 915.630 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectra 0039/0040](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001/0004) Mycobacterium chitae(Ref. 0001/0004) Mycobacterium smegmatis(Ref. 0001/0004) Mycobacterium parafortuitum(Ref. 0001) Mycobacterium vaccae(Ref. 0001/0004) Mycobacterium duvalii(Ref. 0001/0004) Mycobacterium thermoresistibile lab.(Ref. 0001/0004) Mycobacterium aurum(Ref. 0001/0004) Mycobacterium pulveris(Ref. 0004) Mycobacterium shimoidei(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 170 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C41:1 acid |
MMA0170 | Nagatoshi Fujiwara |
C39:1(b-unit)+C24:0(a-unit) |
C63H124O3 | 929.657 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 171 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C42:1 acid |
MMA0171 | Nagatoshi Fujiwara |
C40:1(b-unit)+C24:0(a-unit) |
C64H126O3 | 943.683 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0041](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001/0004) Mycobacterium chitae(Ref. 0001/0004) Mycobacterium smegmatis(Ref. 0001/0004) Mycobacterium vaccae(Ref. 0004) Mycobacterium agri(Ref. 0004) Mycobacterium duvalii(Ref. 0001/0004) Mycobacterium thermoresistibile lab.(Ref. 0001/0004) Mycobacterium aurum(Ref. 0001/0004) Mycobacterium pulveris(Ref. 0004) Mycobacterium shimoidei(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 172 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C43:1 acid |
MMA0172 | Nagatoshi Fujiwara |
C41:1(b-unit)+C24:0(a-unit) |
C65H128O3 | 957.710 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 173 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C45:1 acid |
MMA0173 | Nagatoshi Fujiwara |
C43:1(b-unit)+C24:0(a-unit) |
C67H132O3 | 985.763 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 174 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C44:1 acid |
MMA0174 | Nagatoshi Fujiwara |
C42:1(b-unit)+C24:0(a-unit) |
C66H130O3 | 971.737 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0042](Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001/0004) Mycobacterium chitae(Ref. 0001/0004) Mycobacterium smegmatis(Ref. 0001/0004) Mycobacterium agri(Ref. 0001/0004) Mycobacterium duvalii(Ref. 0001/0004) Mycobacterium thermoresistibile lab.(Ref. 0001/0004) Mycobacterium aurum(Ref. 0001/0004) Mycobacterium pulveris(Ref. 0004) Mycobacterium shimoidei(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 175 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C46:1 acid |
MMA0175 | Nagatoshi Fujiwara |
C44:1(b-unit)+C24:0(a-unit) |
C68H134O3 | 999.790 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 176 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C47:1 acid |
MMA0176 | Nagatoshi Fujiwara |
C45:1(b-unit)+C24:0(a-unit) |
C69H136O3 | 1013.816 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium agri(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 177 |  |
Monoenoic-a'-mycolic acid |
2-Docosanoyl,3-hydroxy-C48:1 acid |
MMA0177 | Nagatoshi Fujiwara |
C46:1(b-unit)+C24:0(a-unit) |
C70H138O3 | 1027.843 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium agri(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 178 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C36:1 acid |
MMA0178 | Nagatoshi Fujiwara |
C34:1(b-unit)+C22:0(a-unit) |
C56H110O3 | 831.471 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 179 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C38:1 acid |
MMA0179 | Nagatoshi Fujiwara |
C36:1(b-unit)+C22:0(a-unit) |
C58H114O3 | 859.524 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 180 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C39:1 acid |
MMA0180 | Nagatoshi Fujiwara |
C37:1(b-unit)+C22:0(a-unit) |
C59H116O3 | 873.551 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 181 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C40:1 acid |
MMA0181 | Nagatoshi Fujiwara |
C38:1(b-unit)+C22:0(a-unit) |
C60H118O3 | 887.577 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chitae(Ref. 0001/0004) Mycobacterium smegmatis(Ref. 0001) Mycobacterium parafortuitum(Ref. 0001/0004) Mycobacterium vaccae(Ref. 0001/0004) Mycobacterium duvalii(Ref. 0001/0004) Mycobacterium thermoresistibile lab.(Ref. 0001) Mycobacterium aurum(Ref. 0001/0004) Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 182 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C41:1 acid |
MMA0182 | Nagatoshi Fujiwara |
C39:1(b-unit)+C22:0(a-unit) |
C61H120O3 | 901.604 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 183 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C42:1 acid |
MMA0183 | Nagatoshi Fujiwara |
C40:1(b-unit)+C22:0(a-unit) |
C62H122O3 | 915.630 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium chelonae(Ref. 0001/0004) Mycobacterium smegmatis(Ref. 0001) Mycobacterium parafortuitum(Ref. 0001/0004) Mycobacterium vaccae(Ref. 0001/0004) Mycobacterium duvalii(Ref. 0001/0004) Mycobacterium thermoresistibile lab.(Ref. 0001) Mycobacterium aurum(Ref. 0001/0004) Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 184 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C43:1 acid |
MMA0184 | Nagatoshi Fujiwara |
C41:1(b-unit)+C22:0(a-unit) |
C63H124O3 | 929.657 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 185 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C44:1 acid |
MMA0185 | Nagatoshi Fujiwara |
C42:1(b-unit)+C22:0(a-unit) |
C64H126O3 | 943.683 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 186 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C45:1 acid |
MMA0186 | Nagatoshi Fujiwara |
C43:1(b-unit)+C22:0(a-unit) |
C65H128O3 | 957.710 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium pulveris(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 187 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C46:1 acid |
MMA0187 | Nagatoshi Fujiwara |
C44:1(b-unit)+C22:0(a-unit) |
C66H130O3 | 971.737 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 188 |  |
Monoenoic-a'-mycolic acid |
2-Eicosanoyl,3-hydroxy-C48:1 acid |
MMA0188 | Nagatoshi Fujiwara |
C46:1(b-unit)+C22:0(a-unit) |
C68H134O3 | 999.790 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
||||||||||||||
| 189 |  |
Monoenoic-a'-mycolic acid |
2-Tetrcosanoyl,3-hydroxy-C40:1 acid |
MMA0189 | Nagatoshi Fujiwara |
C38:1(b-unit)+C26:0(a-unit) |
C64H126O3 | 943.683 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium simiae(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 190 |  |
Monoenoic-a'-mycolic acid |
2-Tetracosanoyl,3-hydroxy-C42:1 acid |
MMA0190 | Nagatoshi Fujiwara |
C40:1(b-unit)+C26:0(a-unit) |
C66H130O3 | 971.737 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium simiae(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 191 |  |
Monoenoic-a'-mycolic acid |
2-Tetracosanoyl,3-hydroxy-C44:1 acid |
MMA0191 | Nagatoshi Fujiwara |
C42:1(b-unit)+C26:0(a-unit) |
C68H134O3 | 999.790 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0001/0004/0005) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0013] |
Mycobacterium simiae(Ref. 0004) |
As a'-mycolic acid in Mycobacterium smegmatis, x=21, l=17,19, m=15,17,19,21(Ref. 0012)x=21, C60,62,64,66,68,74-83(Ref. 0013)x=21, C60-66(Ref. 0003)effect of growth temperature(Ref. 0002) As a'-mycolic acid in Mycobacterium phlei, effect of growth temperature(Ref. 0010) As a'-mycolic acid in Mycobacterium chelonei, x=21, l=15,17, m=17,19 C60-64(Ref. 0009) |
|||||||||||||
| 192 |  |
Hydroxy-mycolic acid |
2-Docosanoyl,3,32-dihydroxy,33-methyl-C50:1 acid |
MMA0192 | Nagatoshi Fujiwara |
30-OH,31-CH3-C48:1(b-unit)+C24:0(a-unit) |
C73H144O4 | 1085.922 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0002/0003) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0014/0015] |
Mycobacterium smegumatis(Ref. 0002) |
||||||||||||||
| 193 |  |
Hydroxy-mycolic acid |
2-Docosanoyl,3,34-dihydroxy,35-methyl-C52:1 acid |
MMA0193 | Nagatoshi Fujiwara |
32-OH,33-CH3-C50:1(b-unit)+C24:0(a-unit) |
C75H148O4 | 1113.975 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0043](Ref. 0002/0003) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0014/0015] |
Mycobacterium smegumatis(Ref. 0002) |
||||||||||||||
| 194 |  |
Hydroxy-mycolic acid |
2-Docosanoyl,3,36-dihydroxy,37-methyl-C54:1 acid |
MMA0194 | Nagatoshi Fujiwara |
34-OH,35-CH3-C52:1(b-unit)+C24:0(a-unit) |
C77H152O4 | 1142.028 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0044](Ref. 0002/0003) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0014/0015] |
Mycobacterium smegumatis(Ref. 0002) |
||||||||||||||
| 195 |  |
Hydroxy-mycolic acid |
2-Docosanoyl,3,38-dihydroxy,39-methyl-C56:1 acid |
MMA0195 | Nagatoshi Fujiwara |
36-OH,37-CH3-C54:1(b-unit)+C24:0(a-unit) |
C79H156O4 | 1170.082 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) [Spectrum 0045](Ref. 0002/0003) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0014/0015] |
Mycobacterium smegumatis(Ref. 0002) |
||||||||||||||
| 196 |  |
Epoxy mycolic acid |
2-Docosanoyl,3-hydroxy,monoD,39-methyl-C57 acid |
MMA0196 | Nagatoshi Fujiwara |
37-CH3,3C54-monoD(b-unit)+C24:0(a-unit) |
C79H159O3 | 1157.106 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0002/0003) |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatograms 0014/0015](Ref. 0196) |
|||||||||||||||
| 197 |  |
Methoxy mycolic acid |
2-Tetracosanoyl,3-hydroxy,monoD,33-methoxy,34-methyl C51 acid (C53, 55, 57, 59, 61) |
MMA0197 | Nagatoshi Fujiwara |
31-OCH3,32-CH3,C49-monoD(b-unit)+C26:0(a-unit) |
C77H152O4 | 1142.028 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) (Ref. 0008> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 |
Mycobacterium microti(Ref. 0008) |
||||||||||||||
| 198 |  |
Methoxy-mycolic acid |
2-Tetracosanoyl,3-hydroxy,39-methoxy,40-methyl-monocyclopropanoyl-C61:0 acid |
MMA0198 | Nagatoshi Fujiwara |
37-OCH3,38-CH3,C57-monoD(b-unit)+C26:0(a-unit) |
C85H168O4 | 1254.241 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032/0050) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) FAB/MS spectrum with 3-nitrobenzylalchol/triethylene glycol mono-n-butyl ether (1:1) as matrix [Spectrum 0046](Ref. 0045> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0016](Ref. 0028/0056/0058) |
Mycobacterium tuberculosis(Ref. 0045) |
||||||||||||||
| 199 |  |
Methoxy-mycolic acid |
2-Tetracosanoyl,3-hydroxy,37-methoxy,38-methyl-monocyclopropanoyl-C59:0 acid |
MMA0199 | Nagatoshi Fujiwara |
35-OCH3,36-CH3,C55-monoD(b-unit)+C26:0(a-unit) |
C83H164O4 | 1226.188 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032/0050) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) FAB/MS spectrum with 3-nitrobenzylalchol/triethylene glycol mono-n-butyl ether (1:1) as matrix [Spectrum 0046](Ref. 0045> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0016](Ref. 0028/0056/0058) |
Mycobacterium tuberculosis(Ref. 0045) |
||||||||||||||
| 200 |  |
Methoxy-mycolic acid |
2-Tetracosanoyl,3-hydroxy,41-methoxy,42-methyl-monocyclopropanoyl-C63:0 acid |
MMA0200 | Nagatoshi Fujiwara |
39-OCH3,40-CH3,C59-monoD(b-unit)+C26:0(a-unit) |
C87H172O4 | 1282.294 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032/0050) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) FAB/MS spectrum with 3-nitrobenzylalchol/triethylene glycol mono-n-butyl ether (1:1) as matrix [Spectrum 0046](Ref. 0045> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0016](Ref. 0028/0056/0058) |
Mycobacterium tuberculosis(Ref. 0045) |
||||||||||||||
| 201 |  |
Keto mycolic acid |
2-Tetracosanoyl,3-hydroxy,42-methoxy,43-methyl-monocyclopropanoyl-C63:0 acid |
MMA0201 | Nagatoshi Fujiwara |
40-keto,41-CH3,C60-monoD(b-unit)+C26:0(a-unit) |
C87H170O4 | 1280.278 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060/0061/0062) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032/0050) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) FAB/MS spectrum with 3-nitrobenzylalchol/triethylene glycol mono-n-butyl ether (1:1) as matrix [Spectrum 0047](Ref. 0045> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0016](Ref. 0028/0056/0058) |
Mycobacterium tuberculosis(Ref. 0045) |
||||||||||||||
| 202 |  |
Keto mycolic acid |
2-Tetracosanoyl,3-hydroxy,40-methoxy,41-methyl-monocyclopropanoyl-C62:0 acid |
MMA0202 | Nagatoshi Fujiwara |
39-keto,40-CH3,C59-monoD(b-unit)+C26:0(a-unit) |
C86H168O4 | 1266.252 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060/0061/0062) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032/0050) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) FAB/MS spectrum with 3-nitrobenzylalchol/triethylene glycol mono-n-butyl ether (1:1) as matrix [Spectrum 0047](Ref. 0045> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0016](Ref. 0028/0056/0058) |
Mycobacterium tuberculosis(Ref. 0045) |
||||||||||||||
| 203 |  |
Keto mycolic acid |
2-Tetracosanoyl,3-hydroxy,39-methoxy,40-methyl-monocyclopropanoyl-C61:0 acid |
MMA0203 | Nagatoshi Fujiwara |
38-keto,39-CH3,C58-monoD(b-unit)+C26:0(a-unit) |
C85H166O4 | 1252.225 | |
CD1b-restricted antigen(Ref. 0029) Inhibition of the biosynthesis of mycolic acid by isoniazid(Ref. 0059/0060/0061/0062) (As mycoloyl glycolipid) Granuloma forming activity(Ref. 0031/0032/0050) Toxicity(Ref. 0030/0033) Immunomodifying activities(Ref. 0030) Antitumor activity(Ref. 0037/0039) Adjuvanticity(Ref. 0041/0042) Tumor-necrosis-factor-priming activity(Ref. 0043) In vivo induction of apoptosis in the thymus(Ref. 0040) Activation of protein kinase C(Ref. 0043) Antigenic properties(Ref. 0052/0053/0054) Production of anti-cord factor antibody(Ref. 0045) Increase of anti-cord factor IgG antibody in tuberculous patient(Ref. 0046/0047/0051/0055) Effect of phagocytosis and phagosome-lysosome fusion(Ref. 0050) |
Chloroform,n-Hexane |
[M]+(molecular Ion),[M-15]+(loss of -CH3),[M-90]+(loss of trimethylsilanol),[A]+(TMS-alkoxy ion resulting from C2-C3 cleavage),[A-90]+(loss of trimethylsilanol from [A]+),[B]+(TMS-oxymethylene carboxylic acid ester resulting from C3-C4 cleavage),[B-29]+(loss of CHO from [B]+), (after methylation and trimethylsilylation) FAB/MS spectrum with 3-nitrobenzylalchol/triethylene glycol mono-n-butyl ether (1:1) as matrix [Spectrum 0047](Ref. 0045> |
Thin-layer chromatogram of mycolic acid methyl esters,Chromatogram was developed with a solvent of n-hexane-diethyl ether(4:1, v/v) and visualized with charring after being sprayed with 50% H2SO4 [Chromatogram 0016](Ref. 0028/0056/0058) |
Mycobacterium tuberculosis(Ref. 0045) |
||||||||||||||
| AUTHOR | : | Kaneda, K., Imaizumi, S., and Yano, I. |
| TITLE | : | Distribution of C22-, C24- and C26-alpha-unit-containing mycolic acid homologues in mycobacteria PubMed ID:7494494 |
| JOURNAL | : | Microbiol Immunol. |
| VOL | : | 39 PAGE : 563-570 (1995) |
| AUTHOR | : | Baba, T., Kaneda, K., Kusunose, E., Kusunose, M., and Yano, I. |
| TITLE | : | Thermally adaptive changes of mycolic acids in Mycobacterium smegmatis PubMed ID:2777756 |
| JOURNAL | : | J Biochem (Tokyo). |
| VOL | : | 106 PAGE : 81-86 (1989) |
| AUTHOR | : | Baba, T., Kaneda, K., Kusunose, E., Kusunose, M., and Yano, I. |
| TITLE | : | Molecular species of mycolic acid subclasses in eight strains of Mycobacterium smegmatis PubMed ID:3226228 |
| JOURNAL | : | Lipids. |
| VOL | : | 23 PAGE : 1132-1138 (1988) |
| AUTHOR | : | Kaneda, K., Imaizumi, S., Mizuno, S., Baba, T., Tsukamura, M., and Yano, I. |
| TITLE | : | Structure and molecular species composition of three homologous series of alpha-mycolic acids from Mycobacterium spp PubMed ID:3150979 |
| JOURNAL | : | J Gen Microbiol. |
| VOL | : | 134 PAGE : 2213-2229 (1988) |
| AUTHOR | : | Kaneda, K., Naito, S., Imaizumi, S., Yano, I., Mizuno, S., Tomiyasu, I., Baba, T., Kusunose, E., and Kusunose, M. |
| TITLE | : | Determination of molecular species composition of C80 or longer-chain alpha-mycolic acids in Mycobacterium spp. by gas chromatography-mass spectrometry and mass chromatography PubMed ID:3782454 |
| JOURNAL | : | J Clin Microbiol. |
| VOL | : | 24 PAGE : 1060-1070 (1986) |
| AUTHOR | : | Minnikin, D. E., Minnikin, S. M., Hutchinson, I. G., Goodfellow, M., and Grange, J. M. |
| TITLE | : | Mycolic acid patterns of representative strains of Mycobacterium fortuitum, 'Myobacterium peregrinum' and Mycobacterium smegmatis PubMed ID:6726178 |
| JOURNAL | : | J Gen Microbiol. |
| VOL | : | 130 PAGE : 363-367 (1984) |
| AUTHOR | : | Danielson, S. J., and Gray, G. R. |
| TITLE | : | Structures of the two homologous series of dialkene mycolic acids from Mycobacterium smegmatis PubMed ID:7118938 |
| JOURNAL | : | J Biol Chem. |
| VOL | : | 257 PAGE : 12196-12203 (1982) |
| AUTHOR | : | Davidson, L. A., Draper, P., and Minnikin, D. E. |
| TITLE | : | Studies on the mycolic acids from the walls of Mycobacterium microti PubMed ID:7119747 |
| JOURNAL | : | J Gen Microbiol. |
| VOL | : | 128 PAGE : 823-828 (1982) |
| AUTHOR | : | Minnikin, D. E., Minnikin, S. M., Goodfellow, M., and Stanford, J. L. |
| TITLE | : | The mycolic acids of Mycobacterium chelonei PubMed ID:7119746 |
| JOURNAL | : | J Gen Microbiol. |
| VOL | : | 128 PAGE : 817-822 (1982) |
| AUTHOR | : | Toriyama, S., Yano, I., Masui, M., Kusunose, E., Kusunose, M., and Akimori, N. |
| TITLE | : | Regulation of cell wall mycolic acid biosynthesis in acid-fast bacteria. I. Temperature-induced changes in mycolic acid molecular species and related compounds in Mycobacterium phlei PubMed ID:7410334 |
| JOURNAL | : | J Biochem (Tokyo). |
| VOL | : | 88 PAGE : 211-221 (1980) |
| AUTHOR | : | Minnikin,D.E.,Hutchinson,I.G., and Caldicott,A.B. |
| TITLE | : | Thin-Layer Chromatography of Methanolysates of Mycolic Acid-Containing Bacteria. |
| JOURNAL | : | J. Chromatogr. |
| VOL | : | 188 PAGE : 221-233 (1980) |
| AUTHOR | : | Wong, M. Y., and Gray, G. R. |
| TITLE | : | Structures of the homologous series of monoalkene mycolic acids from Mycobacterium smegmatis PubMed ID:447681 |
| JOURNAL | : | J Biol Chem. |
| VOL | : | 254 PAGE : 5741-5744 (1979) |
| AUTHOR | : | Wong, M. Y., Steck, P. A., and Gray, G. R. |
| TITLE | : | The major mycolic acids of Mycobacterium smegmatis. Characterization of their homologous series PubMed ID:447680 |
| JOURNAL | : | J Biol Chem. |
| VOL | : | 254 PAGE : 5734-5740 (1979) |
| AUTHOR | : | Toriyama, S., Yano, I., Masui, M., Kusunose, M., and Kusunose, E. |
| TITLE | : | Separation of C50--60 and C70--80 mycolic acid molecular species and their changes by growth temperatures in Mycobacterium phlei PubMed ID:720589 |
| JOURNAL | : | FEBS Lett. |
| VOL | : | 95 PAGE : 111-115 (1978) |
| AUTHOR | : | Steck, P. A., Schwartz, B. A., Rosendahl, M. S., and Gray, G. R. |
| TITLE | : | Mycolic acids. A reinvestigation PubMed ID:97301 |
| JOURNAL | : | J Biol Chem. |
| VOL | : | 253 PAGE : 5625-5629 (1978) |
| AUTHOR | : | Qureshi, N., Takayama, K., Jordi, H. C., and Schnoes, H. K. |
| TITLE | : | Characterization of the purified components of a new homologous series of alpha-mycolic acids from Mycobacterium tuberculosis H37Ra PubMed ID:97292 |
| JOURNAL | : | J Biol Chem. |
| VOL | : | 253 PAGE : 5411-5417 (1978) |
| AUTHOR | : | Lederer, E., Adam, A., Ciorbaru, R., Petit, J. F., and Wietzerbin, J. |
| TITLE | : | Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties PubMed ID:1095912 |
| JOURNAL | : | Mol Cell Biochem. |
| VOL | : | 7 PAGE : 87-104 (1975) |
| AUTHOR | : | Minnikin, D. E., Alshamaony, L., and Goodfellow, M. |
| TITLE | : | Differentiation of Mycobacterium, Nocardia, and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates PubMed ID:1151335 |
| JOURNAL | : | J Gen Microbiol. |
| VOL | : | 88 PAGE : 200-204 (1975) |
| AUTHOR | : | Tomiyasu, I., and Yano, I. |
| TITLE | : | Isonicotinic acid hydrazide induced changes and inhibition in mycolic acid synthesis in Nocardia and related taxa PubMed ID:6428369 |
| JOURNAL | : | Arch Microbiol. |
| VOL | : | 137 PAGE : 316-323 (1984) |
| AUTHOR | : | Tomiyasu, I. |
| TITLE | : | Mycolic acid composition and thermally adaptative changes in Nocardia asteroides PubMed ID:7047498 |
| JOURNAL | : | J Bacteriol. |
| VOL | : | 151 PAGE : 828-837 (1982) |
| AUTHOR | : | Tomiyasu,I.,Toriyama,I.,Yano,I., and Masui,M. |
| TITLE | : | Changes in Molecular Species Composition of Nocardomycolic Acids in Nocardia Rubra by the Growth Temperature. |
| JOURNAL | : | Chem. Phys. Lipids |
| VOL | : | 28 PAGE : 41-54 (1981) |
| AUTHOR | : | Yano, I., Kageyama, K., Ohno, Y., Masui, M., Kusunose, E., Kusunose, M., and Akimori, N. |
| TITLE | : | Separation and analysis of molecular species of mycolic acids in Nocardia and related taxa by gas chromatography mass spectrometry PubMed ID:623888 |
| JOURNAL | : | Biomed Mass Spectrom. |
| VOL | : | 5 PAGE : 14-24 (1978) |
| AUTHOR | : | Yano, I., Saito, K., Furukawa, Y., and Kusunose, M. |
| TITLE | : | Structural analysis of molecular species of nocardomycolic acids from Nocardia erythropolis by the combined system of gas chromatography and mass spectrometry PubMed ID:11946513 |
| JOURNAL | : | FEBS Lett. |
| VOL | : | 21 PAGE : 215-219 (1972) |
| AUTHOR | : | Tomiyasu, I., and Yano, I. |
| TITLE | : | Separation and analysis of novel polyunsaturated mycolic acids from a psychrophilic, acid-fast bacterium, Gordona aurantiaca PubMed ID:6698005 |
| JOURNAL | : | Eur J Biochem. |
| VOL | : | 139 PAGE : 173-180 (1984) |
| AUTHOR | : | Wada,H.,Okada,H.,Suginaka,H.,Tomiyasu,I., and Yano,I. |
| TITLE | : | Gas Chromatographic and Mass Spectrometric Analysis of Molecular Species of Bacterionemamycolic Acids from Bacterionema matruchotii. |
| JOURNAL | : | FEMS Microbiol. Lett. |
| VOL | : | 11 PAGE : 187-192 (1981) |
| AUTHOR | : | Gailly, C., Sandra, P., Verzele, M., and Cocito, C. |
| TITLE | : | Analysis of mycolic acids from a group of corynebacteria by capillary gas chromatography and mass spectrometry PubMed ID:7106128 |
| JOURNAL | : | Eur J Biochem. |
| VOL | : | 125 PAGE : 83-94 (1982) |
| AUTHOR | : | Yano, I., and Saito, K. |
| TITLE | : | Gas chromatographic and mass spectrometric analysis of molecular species of corynomycolic acids from Corynebacterium ulcerans PubMed ID:11946651 |
| JOURNAL | : | FEBS Lett. |
| VOL | : | 23 PAGE : 352-356 (1972) |
| AUTHOR | : | Besra,G.S.,and Chatterjee,D. (1994) Lipids and Carbohydrates of Mycobacterium tuberculosis (Bloom,B.R., eds), pp285-306, In Tuberculosis Asm Press, Washington Dc |
| TITLE | : | |
| JOURNAL | : | |
| VOL | : | PAGE : - () |
| AUTHOR | : | Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., and Brenner, M. B. |
| TITLE | : | Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells PubMed ID:7527500 |
| JOURNAL | : | Nature. |
| VOL | : | 372 PAGE : 691-694 (1994) |
| AUTHOR | : | Asselineau,C., and Asselineau,J. (1978) Trehalose-containing Glycolipids (Prog. Chem. Fats other Lipids. Vol. 16, pp59-99, Pergamon Press, Great Britain |
| TITLE | : | |
| JOURNAL | : | |
| VOL | : | PAGE : - () |
| AUTHOR | : | Goren,M.B. (1972) Mycobacterial Lipids: Selected Topics Bacteriological Reviews, pp33-64, American Society for Microbiology |
| TITLE | : | |
| JOURNAL | : | |
| VOL | : | PAGE : - () |
| AUTHOR | : | Bekierkunst, A., Levij, I. S., Yarkoni, E., Vilkas, E., Adam, A., and Lederer, E. |
| TITLE | : | Granuloma formation induced in mice by chemically defined mycobacterial fractions PubMed ID:4981067 |
| JOURNAL | : | J Bacteriol. |
| VOL | : | 100 PAGE : 95-102 (1969) |
| AUTHOR | : | S.S.Syed,B.S., and Hunter,L.L.,Jr. |
| TITLE | : | Studies on the Toxic Effects of Quartz and a Mycobacterial Glycolipid, Trehalose 6,6'-Dimycolate. PubMed ID:9303177 |
| JOURNAL | : | Ann. Clin. Lab. Sci. |
| VOL | : | 27 PAGE : 375-383 (1997) |
| AUTHOR | : | Natsuhara, Y., Yoshinaga, J., Shogaki, T., Sumi-Nishikawa, Y., Kurano, S., Kato, Y., Kaneda, K., Oka, S., and Yano, I. |
| TITLE | : | Granuloma-forming activity and antitumor activity of newly isolated mycoloyl glycolipid from Rhodococcus terrae 70012 (Rt. GM-2) PubMed ID:2325578 |
| JOURNAL | : | Microbiol Immunol. |
| VOL | : | 34 PAGE : 45-53 (1990) |
| AUTHOR | : | Matsunaga,I.,Oka,S.,Inoue,T., and Yano,I. |
| TITLE | : | Mycoloyl Glycolipids Stimulate Macrophages to Release a Chemotactic Factor. |
| JOURNAL | : | FEMS Microbiol.Lett. |
| VOL | : | 67 PAGE : 49-54 (1990) |
| AUTHOR | : | Matsunaga, I., Oka, S., Fujiwara, N., and Yano, I. |
| TITLE | : | Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycoloyl glycolipids from Rhodococcus ruber (Nocardia rubra) PubMed ID:8902634 |
| JOURNAL | : | J Biochem (Tokyo). |
| VOL | : | 120 PAGE : 663-670 (1996) |
| AUTHOR | : | Lepoivre, M., Tenu, J. P., Lemaire, G., and Petit, J. F. |
| TITLE | : | Antitumor activity and hydrogen peroxide release by macrophages elicited by trehalose diesters PubMed ID:6806386 |
| JOURNAL | : | J Immunol. |
| VOL | : | 129 PAGE : 860-866 (1982) |
| AUTHOR | : | Natsuhara, Y., Oka, S., Kaneda, K., Kato, Y., and Yano, I. |
| TITLE | : | Parallel antitumor, granuloma-forming and tumor-necrosis-factor-priming activities of mycoloyl glycolipids from Nocardia rubra that differ in carbohydrate moiety: structure-activity relationships PubMed ID:2322938 |
| JOURNAL | : | Cancer Immunol Immunother. |
| VOL | : | 31 PAGE : 99-106 (1990) |
| AUTHOR | : | Orbach-Arbouys, S., Tenu, J. P., and Petit, J. F. |
| TITLE | : | Enhancement of in vitro and in vivo antitumor activity by cord factor (6-6'-dimycolate of trehalose) administered suspended in saline PubMed ID:6403475 |
| JOURNAL | : | Int Arch Allergy Appl Immunol. |
| VOL | : | 71 PAGE : 67-73 (1983) |
| AUTHOR | : | Ozeki, Y., Kaneda, K., Fujiwara, N., Morimoto, M., Oka, S., and Yano, I. |
| TITLE | : | In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6'-dimycolate) PubMed ID:9125563 |
| JOURNAL | : | Infect Immun. |
| VOL | : | 65 PAGE : 1793-1799 (1997) |
| AUTHOR | : | Bekierkunst,A. (1984) Adjuvanticity of Mycobacteria and their Glycolipid Components, Wax D and Cord Factors (Kubica,G.P. and Wayne,L.G., eds), pp761-786, The Mycobacteria: A Sourcebook Part B Marcel Dekker, New York |
| TITLE | : | |
| JOURNAL | : | |
| VOL | : | PAGE : - () |
| AUTHOR | : | Azuma, I., Kishimoto, S., Yamamura, Y., and Petit, J. F. |
| TITLE | : | Adjuvanticity of mycobacterial cell walls PubMed ID:4930810 |
| JOURNAL | : | Jpn J Microbiol. |
| VOL | : | 15 PAGE : 193-197 (1971) |
| AUTHOR | : | Sueoka, E., Nishiwaki, S., Okabe, S., Iida, N., Suganuma, M., Yano, I., Aoki, K., and Fujiki, H. |
| TITLE | : | Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-alpha release in mouse lung tissues PubMed ID:7559098 |
| JOURNAL | : | Jpn J Cancer Res. |
| VOL | : | 86 PAGE : 749-755 (1995) |
| AUTHOR | : | Levy-Frebault, V., Daffe, M., Goh, K. S., Laneelle, M. A., Asselineau, C., and David, H. L. |
| TITLE | : | Identification of Mycobacterium fortuitum and Mycobacterium chelonei PubMed ID:6190837 |
| JOURNAL | : | J Clin Microbiol. |
| VOL | : | 17 PAGE : 744-752 (1983) |
| AUTHOR | : | Fujiwara, N., Pan, J., Enomoto, K., Terano, Y., Honda, T., and Yano, I. |
| TITLE | : | Production and partial characterization of anti-cord factor (trehalose-6,6'-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclasses of Mycobacterium tuberculosis or Mycobacterium avium PubMed ID:10378413 |
| JOURNAL | : | FEMS Immunol Med Microbiol. |
| VOL | : | 24 PAGE : 141-149 (1999) |
| AUTHOR | : | He,H.,Oka,S.,Han,Y.,Yamamura,Y.,Kusunose,E.,Kusunose,M., and Yano,I. |
| TITLE | : | Rapid Serodiagnosis of Human Mycobacteriosis by ELISA Using Cord Factor (Trehalose-6,6'-Dimycolate) Purified from Mycobacterium tuberculosis as Antigen.. PubMed ID:1931132 |
| JOURNAL | : | FEMS Microbiol.Immunol. |
| VOL | : | 3 PAGE : 201-204 (1991) |
| AUTHOR | : | Maekura, R., Nakagawa, M., Nakamura, Y., Hiraga, T., Yamamura, Y., Ito, M., Ueda, E., Yano, S., He, H., Oka, S., et al. |
| TITLE | : | Clinical evaluation of rapid serodiagnosis of pulmonary tuberculosis by ELISA with cord factor (trehalose-6,6'-dimycolate) as antigen purified from Mycobacterium tuberculosis PubMed ID:8214957 |
| JOURNAL | : | Am Rev Respir Dis. |
| VOL | : | 148 PAGE : 997-1001 (1993) |
| AUTHOR | : | Kaneda, K., Sumi, Y., Kurano, F., Kato, Y., and Yano, I. |
| TITLE | : | Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra PubMed ID:3781628 |
| JOURNAL | : | Infect Immun. |
| VOL | : | 54 PAGE : 869-875 (1986) |
| AUTHOR | : | Fujita,T.,Sugimoto,N.,Yokoi,F.,Ohtsubo,Y.,Ikutoh,M.,Kato,Y.,Natsuhara,Y.,Oka,S., and Yano,I. |
| TITLE | : | Induction of Interferons (IFNs) and Tumor Necrosis Factor (TNF) in Mice by a Novel Glycolipid Trehalose 2,3,6'-trimycolate from Rhodococcus aurantiacus (Gordona aurantiaca). PubMed ID:1699114 |
| JOURNAL | : | Microbiol.Immunol. |
| VOL | : | 34 PAGE : 523-532 (1990) |
| AUTHOR | : | Fujiwara, N. |
| TITLE | : | [Distribution of antigenic glycolipids among Mycobacterium tuberculosis strains and their contribution to virulence] PubMed ID:9145649 |
| JOURNAL | : | Kekkaku. |
| VOL | : | 72 PAGE : 193-205 (1997) |
| AUTHOR | : | Enomoto,K.,Oka,S.,Fujiwara,N.,Okamoto,T.,Okuda,Y.,Maekura,R.,Kuroki,T., and Yano,I. |
| TITLE | : | Rapid Serodiagnosis of Mycobacterium avium-intracellulare Complex Infection by ELISA with Cord Factor (Trehalose 6,6'-Dimycolate), and Serotyping Using the Glycopeptidolipid Antigen. PubMed ID:9858464 |
| JOURNAL | : | Microbiol.Immunol. |
| VOL | : | 42 PAGE : 689-696 (1998) |
| AUTHOR | : | Kato, M. |
| TITLE | : | Antibody formation to trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis PubMed ID:4117880 |
| JOURNAL | : | Infect Immun. |
| VOL | : | 5 PAGE : 203-212 (1972) |
| AUTHOR | : | Kato, M. |
| TITLE | : | Immunochemical properties of anti-cord factor antibody PubMed ID:4120358 |
| JOURNAL | : | Infect Immun. |
| VOL | : | 7 PAGE : 9-13 (1973) |
| AUTHOR | : | Kato, M. |
| TITLE | : | Effect of anti-cord factor antibody on experimental tuberculosis in mice PubMed ID:4632133 |
| JOURNAL | : | Infect Immun. |
| VOL | : | 7 PAGE : 14-21 (1973) |
| AUTHOR | : | Kawamura, M., Sueshige, N., Imayoshi, K., Yano, I., Maekura, R., and Kohno, H. |
| TITLE | : | Enzyme immunoassay to detect antituberculous glycolipid antigen (anti-TBGL antigen) antibodies in serum for diagnosis of tuberculosis PubMed ID:9138102 |
| JOURNAL | : | J Clin Lab Anal. |
| VOL | : | 11 PAGE : 140-145 (1997) |
| AUTHOR | : | Noll, H., Bloch, H., Asselineau, J., and Lederer, E. |
| TITLE | : | The chemical structure of the cord factor of Mycobacterium tuberculosis PubMed ID:13328853 |
| JOURNAL | : | Biochim Biophys Acta. |
| VOL | : | 20 PAGE : 299-309 (1956) |
| AUTHOR | : | Yano, I., Tomiyasu, I., Kitabatake, S., and Kaneda, K. |
| TITLE | : | Granuloma forming activity of mycolic acid-containing glycolipids in nocardia and related taxa PubMed ID:6398593 |
| JOURNAL | : | Acta Leprol. |
| VOL | : | 2 PAGE : 341-349 (1984) |
| AUTHOR | : | Chaicumpar, K., Fujiwara, N., Nishimura, O., Hotta, H., Pan, J. W., Takahashi, M., Abe, C., and Yano, I. |
| TITLE | : | Studies of polymorphic DNA fingerprinting and lipid pattern of Mycobacterium tuberculosis patient isolates in Japan PubMed ID:9087953 |
| JOURNAL | : | Microbiol Immunol. |
| VOL | : | 41 PAGE : 107-119 (1997) |
| AUTHOR | : | Takayama, K., Schnoes, H. K., Armstrong, E. L., and Boyle, R. W. |
| TITLE | : | Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis PubMed ID:806645 |
| JOURNAL | : | J Lipid Res. |
| VOL | : | 16 PAGE : 308-317 (1975) |
| AUTHOR | : | Winder, F. G., and Collins, P. B. |
| TITLE | : | Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis PubMed ID:5500025 |
| JOURNAL | : | J Gen Microbiol. |
| VOL | : | 63 PAGE : 41-48 (1970) |
| AUTHOR | : | Dubnau, E., Laneelle, M. A., Soares, S., Benichou, A., Vaz, T., Prome, D., Prome, J. C., Daffe, M., and Quemard, A. |
| TITLE | : | Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids PubMed ID:9044265 |
| JOURNAL | : | Mol Microbiol. |
| VOL | : | 23 PAGE : 313-322 (1997) |
| AUTHOR | : | Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., and Barry, C. E., 3rd |
| TITLE | : | Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid PubMed ID:9616124 |
| JOURNAL | : | Science. |
| VOL | : | 280 PAGE : 1607-1610 (1998) |